BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29321013)

  • 21. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
    Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis.
    Siddiqui MS; Van Natta ML; Connelly MA; Vuppalanchi R; Neuschwander-Tetri BA; Tonascia J; Guy C; Loomba R; Dasarathy S; Wattacheril J; Chalasani N; Sanyal AJ;
    J Hepatol; 2020 Jan; 72(1):25-33. PubMed ID: 31634532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute changes in lipoprotein subclasses during exercise.
    Søndergaard E; Poulsen MK; Jensen MD; Nielsen S
    Metabolism; 2014 Jan; 63(1):61-8. PubMed ID: 24075739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS.
    Wood AC; Glasser S; Garvey WT; Kabagambe EK; Borecki IB; Tiwari HK; Tsai MY; Hopkins PN; Ordovas JM; Arnett DK
    Lipids Health Dis; 2011 Aug; 10():143. PubMed ID: 21854610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of insulin resistance and obesity on low-density lipoprotein particle size in children.
    Taşcılar ME; Özgen T; Cihan M; Abacı A; Yeşilkaya E; Eker I; Serdar M
    J Clin Res Pediatr Endocrinol; 2010; 2(2):63-6. PubMed ID: 21274340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
    Sam S; Haffner S; Davidson MH; D'Agostino RB; Feinstein S; Kondos G; Perez A; Mazzone T
    Diabetes; 2008 Aug; 57(8):2022-7. PubMed ID: 18469202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler AJ; Brown WV; Lyons TJ; Garvey WT;
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL; Bjerve KS; Lydersen S; Grill V
    Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Lyons TJ; Jenkins AJ; Zheng D; Lackland DT; McGee D; Garvey WT; Klein RL
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):910-8. PubMed ID: 14985310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
    Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
    Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of obesity on HDL and LDL particle sizes in carriers of the null P207L or defective D9N mutation in the lipoprotein lipase gene: the Québec LipD Study.
    Ruel IL; Gaudet D; Perron P; Bergeron J; Julien P; Lamarche B;
    Int J Obes Relat Metab Disord; 2003 May; 27(5):631-7. PubMed ID: 12704407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients: A cross-sectional study.
    Chen J; Li J; Wang J; Zeng D; Chen J; Zhang Y; Wu M; Zhang D; Hong X
    Clin Exp Hypertens; 2021 Jan; 43(1):26-33. PubMed ID: 32727222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50-65 years.
    Burdge GC; Powell J; Dadd T; Talbot D; Civil J; Calder PC
    Br J Nutr; 2009 Jul; 102(1):160-5. PubMed ID: 19138437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance.
    Hyötyläinen T; Mattila I; Wiedmer SK; Koivuniemi A; Taskinen MR; Yki-Järvinen H; Orešič M
    Mol Biosyst; 2012 Oct; 8(10):2559-65. PubMed ID: 22722885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low density lipoprotein particle size and risk factors of insulin resistance syndrome.
    Friedlander Y; Kidron M; Caslake M; Lamb T; McConnell M; Bar-On H
    Atherosclerosis; 2000 Jan; 148(1):141-9. PubMed ID: 10580180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.